Clinical Trials Browser

Phase 2/3 × Pancreatic Neoplasms × Levobupivacaine × Clear all

NCT02356640 2019-01-30

EUS-guided CGN for Inoperable Cancer

Phase 2/3 Terminated

Gastrointestinal

Pancreatic Neoplasms